Sm. Mariani et al., REGULATION OF CELL-SURFACE APO-1 FAS (CD95) LIGAND EXPRESSION BY METALLOPROTEASES/, European Journal of Immunology, 25(8), 1995, pp. 2303-2307
APO-1/Fas (CD95) ligand (APO-1L) induces apoptosis in sensitive target
cells. Activation-induced T cell death and Ca2+-independent cytotoxic
ity in perforin knockout mice are mediated by APO-1L. To define whethe
r APO-1L is expressed on the surface of activated T cells and to inves
tigate the mechanisms leading to the release of a soluble form, we dev
eloped rabbit anti-APO-IL antibodies (Ab). The purified rabbit Ab dete
cted the mature forms of the human and mouse APO-1L of approximately 4
2 and 40 kDa. In addition, the Ab recognized the non-glycosylated form
of APO-1L of approximately 32-33 kDa. In activated human T cells, the
soluble form of APO-1L was detectable with a moleculas mass of 26 kDa
. Immunofluorescence of three human T lymphoblastoid cell lines showed
that activation of these cells by phorbol 12-myristate 13-acetate/ion
omycin induced a significant increase in cell surface APO-1L only in t
he presence of metalloprotease inhibitors. Zn2+, but not Ca2+, prevent
ed the increase in surface APO-1L observed in the presence of 1,10-phe
nanthroline. Blocking of other classes of proteases (serine- and acid-
proteases, chymotrypsin) had no effect. Increased expression of surfac
e APO-1L by metalloprotease inhibitors was not dependent on T cell act
ivation, as the metalloprotease inhibitors also modulated the low leve
l of constitutive APO-1L expression. These results suggest that cell s
urface expression of human APO-1L is regulated by Zn2+-dependent metal
loproteases. Cleavage of surface APO-1L may act as a regulatory mechan
ism to prevent accumulation of the membrane-bound form and may cause s
ystemic effects of the APO-1L.